Enanta Pharmaceuticals (ENTA) EPS (Basic) Growth (1y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -13.31% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -100.00% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -79.34% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 61.11% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -3,856.63% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -7.78% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1,207.14% |
| 10 | Enanta Pharmaceuticals | 367.22 Mn | 203.44 Mn | - | 57.55% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 57.55% |
| Dec 31, 2025 | 60.00% |
| Sep 30, 2025 | 35.29% |
| Jun 30, 2025 | 20.56% |
| Mar 31, 2025 | 27.89% |
| Dec 31, 2024 | 33.54% |
| Sep 30, 2024 | -2.26% |
| Jun 30, 2024 | 42.47% |
| Mar 31, 2024 | 17.88% |
| Dec 31, 2023 | -13.67% |
| Sep 30, 2023 | -4.72% |
| Jun 30, 2023 | -21.57% |
| Mar 31, 2023 | -9.82% |
| Dec 31, 2022 | 6.08% |
| Sep 30, 2022 | -4.10% |
| Jun 30, 2022 | -28.57% |
| Mar 31, 2022 | -49.54% |
| Dec 31, 2021 | -260.98% |
| Sep 30, 2021 | 16.44% |
| Jun 30, 2021 | -67.61% |
| Mar 31, 2021 | -263.33% |
| Dec 31, 2020 | -160.29% |
| Sep 30, 2020 | -410.64% |
| Jun 30, 2020 | -297.22% |
| Mar 31, 2020 | -242.86% |
| Dec 31, 2019 | -49.25% |
| Sep 30, 2019 | -66.67% |
| Jun 30, 2019 | -65.71% |
| Mar 31, 2019 | -67.69% |
| Dec 31, 2018 | 119.67% |
| Sep 30, 2018 | -26.18% |
| Jun 30, 2018 | 338.64% |
| Mar 31, 2018 | 332.14% |
| Dec 31, 2017 | 334.62% |
| Sep 30, 2017 | 2,222.22% |
| Jun 30, 2017 | -633.33% |
| Mar 31, 2017 | -211.11% |
| Dec 31, 2016 | -118.71% |
| Sep 30, 2016 | -130.00% |
| Jun 30, 2016 | -146.15% |
| Mar 31, 2016 | -105.84% |
| Dec 31, 2015 | -38.50% |
| Sep 30, 2015 | 211.11% |
| Jun 30, 2015 | -95.19% |
| Mar 31, 2015 | 650.00% |
| Dec 31, 2014 | 853.33% |
| Sep 30, 2014 | -8.00% |
| Jun 30, 2014 | 1,273.91% |
| Mar 31, 2014 | 87.72% |
| Dec 31, 2013 | -118.63% |
| Sep 30, 2013 | 94.77% |
| Jun 30, 2013 | 94.66% |
| Mar 31, 2013 | -194.61% |